(13)C-Methacetin Breath Test Predicts Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

The (13)C-methacetin breath test ((13)C-MBT) is a dynamic method for assessing liver function. This proof-of-concept study aimed to investigate the association between (13)C-MBT values and outcomes in patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE). MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Gairing, Simon Johannes, Kuchen, Robert, Müller, Lukas, Cankaya, Alper, Weerts, Jan, Kapucu, Akin, Sachse, Simon, Zimpel, Carolin, Stoehr, Fabian, Pitton, Michael B., Mittler, Jens, Straub, Beate Katharina, Marquardt, Jens Uwe, Schattenberg, Jörn M., Labenz, Christian, Kloeckner, Roman, Weinmann, Arndt, Galle, Peter Robert, Wörns, Marcus-Alexander, Foerster, Friedrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624494/
https://www.ncbi.nlm.nih.gov/pubmed/36087052
http://dx.doi.org/10.14309/ctg.0000000000000529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624494/
https://www.ncbi.nlm.nih.gov/pubmed/36087052
http://dx.doi.org/10.14309/ctg.0000000000000529

Ejemplares similares